Acute myeloid leukemia

Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia

C. Fei, Yao, X. M., Sun, Y., Gu, X. Z., Yu, L. Q., and Lai, X., Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia, vol. 14, pp. 925-930, 2015.

We investigated the association between polymorphisms in interleukin-10 (IL-10) -1082G/A (rs1800896), -819T/C (rs1800871), and -592A/C (rs1800872) and the risk of acute myeloid leukemia (AML) in a Chinese population. A total of 167 primary AML cases and 328 healthy control subjects were recruited at the First People’s Hospital of Yunnan Province between March 2009 and January 2012. The polymorphisms rs1800896, rs1800871, and rs1800872 were genotyped by polymerase chain reaction-restriction fragment length polymorphism.

Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients

Y. Z. Su, Wang, C. B., Zhou, Y., and Sun, N. T., Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients, vol. 14, pp. 5181-5187, 2015.

The present study aimed to explore the changes in serum endostatin and fibroblast growth factor 19 (FGF-19) in acute myeloid leukemia patients, and to determine their effects on chemotherapeutic sensitivity. Sixty acute myeloid leukemia patients and 30 healthy controls were included in the study. Patient serum endostatin and FGF-19 levels were measured on admission, and then, standard chemotherapy was administered.

Association of GSTTI and GSTM1 variants with acute myeloid leukemia risk

Y. M. Zi, Wu, S., Ma, D., Yang, C., Yang, M., Huang, Y., and Yang, S. J., Association of GSTTI and GSTM1 variants with acute myeloid leukemia risk, vol. 13, pp. 3681-3685, 2014.

We aimed to investigate the relationships between polymorphisms of the glutathione S-transferases (GSTs) GSTM1, GSTTI, and GSTP1 and the risk of developing acute myeloid leukemia (AML). A total of 206 AML cases and 231 controls were collected for our study. The genotyping of GSTs (GSTM1, GSTTI, and GSTP1) was based upon the duplex polymerase chain reaction with the confronting two-pair primer (PCR-CTPP) method.

Prognostic implication of molecular aberrations in cytogenetically normal acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation

Y. C. Liu, Hsiao, H. H., Lin, P. M., Yang, W. C., Chang, C. S., Liu, T. C., Hsu, J. F., Yang, M. Y., and Lin, S. F., Prognostic implication of molecular aberrations in cytogenetically normal acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation, vol. 12, pp. 5414-5423, 2013.

Different molecular aberrations can be discriminated into certain prognostic subgroups in cytogenetically normal acute myeloid leukemia (CN-AML) patients but their impact on allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains controversial and studies from Asian populations are lacking. Forty-two adult non-M3 AML patients receiving allo-HSCT from 2002 to 2009 in southern Taiwan were retrospectively reviewed for survey, 23 (54.7%) of whom were CN-AML. NPM1, FLT3-ITD, and CEBPA were analyzed.

Subscribe to Acute myeloid leukemia